Vanderbilt O'Brien Kidney Center-Core A Physiology-Pathiophysiology Core
范德比尔特奥布莱恩肾脏中心-核心生理学-病理生理学核心
基本信息
- 批准号:10163164
- 负责人:
- 金额:$ 31.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAnimalsBioenergeticsCRISPR/Cas technologyClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplementDrug Side EffectsEducationEthylnitrosoureaExperimental ModelsFunctional disorderGene DeliveryGenerationsGenesGeneticGenomeImaging TechniquesImmunotherapyInformation DisseminationInfrastructureInjuryInjury to KidneyInternationalInterventionKidneyKidney DiseasesKidney Function TestsMass Spectrum AnalysisMeasurementMetabolicMetabolismMethodologyMethodsModelingMusMutant Strains MiceMutationOxygenOxygen ConsumptionPathogenesisPharmacologic SubstancePhenotypePhysiologyPilot ProjectsRenal functionReproducibility of ResultsResearchResearch PersonnelResourcesServicesStructureTNFSF5 geneTestingTherapeutic InterventionTimeTissuesTrainingVenousbaseblood flow measurementcost effectivedesigndesign and constructiondrug testingglucose uptakein vivoinsightinterestinvestigator trainingkidney imagingmouse modelmutantnew technologynon-invasive imagingnoveloverexpressionpreventprogramsscreeningtool
项目摘要
ABSTRACT
The Phenotyping and Pathophysiology Core is designed to address the need for effective phenotyping of
kidney function in mouse models of selective gene overexpression or deletion. In addition, this Core is
designed to provide experimental mouse models of acute or progressive renal injury to assess potential
therapeutic interventions. This Core also helps investigators who may have developed genetic mouse models
or potential therapeutic interventions but do not have the expertise and/or infrastructure required to design and
carry out appropriate kidney phenotyping studies or studies investigating mouse models of kidney injury. In this
proposal, we propose five distinct subcores that will offer and/or develop methodologies to define the
pathogenesis of kidney disease and design therapeutic interventions. The Phenotyping Subcore will provide
a battery of well-established invasive and non-invasive tests of kidney function. The Injury Model Subcore will
provide investigators cost-effective testing of potential pharmaceutical or immunologic therapy strategies in
appropriate mouse models of acute or progressive kidney injury. In addition, this subcore will provide murine
models for screening of potential kidney side effects of drugs. This subcore provides a wide variety of
experimental models of mouse kidney injury that offer consistent and reproducible results. Some of the mouse
models available have been developed by the Center investigators. The Metabolism and Bioenergetics
Subcore will offer direct measurements of kidney tissue partial oxygen consumption and will develop
methodology for the measurements of whole kidney oxygen consumption based on kidney blood flow and
measurements of arterial and renal venous partial oxygen. Furthermore this subcore will provide expertise in
metabolic flux analysis, glucose uptake and quantification of various metabolites in kidney tissues using mass
spectrometry methods. The Mouse Kidney Imaging Subcore will provide established non-invasive imaging
techniques for the assessments of mouse renal diseases and will provide methods and further optimize novel
methods for the noninvasive characterization of renal microstructure and function in mice. The CRISPR/cas9
Subcore will provide guidance for the design, construction, and generation of a CRISPR mouse.
In summary, the Phenotyping and Pathophysiology Core provides a broad range of services that aid
researchers interested in utilizing murine models for kidney-related research. The structure of this Core is
unique in that it performs a variety of kidney functions, non-invasive quantitative kidney images analysis, and
experimental platforms for the testing of drugs and interventions. Importantly, this Core performs all these
services in house and directly oversees these studies. We have been very successful in providing these
services not only to the local scientific community interested in kidney research, but also in serving as a
national and international resource.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mingzhi Zhang其他文献
Mingzhi Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mingzhi Zhang', 18)}}的其他基金
Type II 11B-Hydroxysteroid Dehydrogenase and Colorectal Tumorigenesis
II 型 11B-羟基类固醇脱氢酶与结直肠肿瘤发生
- 批准号:
8043556 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Type II 11B-Hydroxysteroid Dehydrogenase and Colorectal Tumorigenesis
II 型 11B-羟基类固醇脱氢酶与结直肠肿瘤发生
- 批准号:
8242886 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Type II 11B-Hydroxysteroid Dehydrogenase and Colorectal Tumorigenesis
II 型 11B-羟基类固醇脱氢酶与结直肠肿瘤发生
- 批准号:
7813894 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Type II 11B-Hydroxysteroid Dehydrogenase and Colorectal Tumorigenesis
II 型 11B-羟基类固醇脱氢酶与结直肠肿瘤发生
- 批准号:
8460969 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Type II 11B-Hydroxysteroid Dehydrogenase and Colorectal Tumorigenesis
II 型 11B-羟基类固醇脱氢酶与结直肠肿瘤发生
- 批准号:
7583323 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Vanderbilt O'Brien Kidney Center-Core A Physiology-Pathiophysiology Core
范德比尔特奥布莱恩肾脏中心-核心生理学-病理生理学核心
- 批准号:
9385113 - 财政年份:
- 资助金额:
$ 31.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Research Grant